Evidence map›Paper›PMID 38014280›Full record

ArticleResearch square2023

Data-driven prediction of continuous renal replacement therapy survival.

Davina Zamanzadeh, Jeffrey Feng, Panayiotis Petousis, Arvind Vepa, Majid Sarrafzadeh, S Ananth Karumanchi, Alex A T Bui, Ira Kurtz

Open access · greenAbstract readPreprint
In one paragraph

Article in Research square, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Davina ZamanzadehDepartment of Computer Science, University of California, Los Angeles, Log Angeles, 90095, California, United States.
Jeffrey FengMedical & Imaging Informatics Group, University of California, Los Angeles, Los Angeles, 90095, California, United States.ORCID https://orcid.org/0000-0002-6927-5200
Panayiotis PetousisClinical and Translation Science Institute, University of California, Los Angeles, Los Angeles, 90095, California, United States.
Arvind VepaMedical & Imaging Informatics Group, University of California, Los Angeles, Los Angeles, 90095, California, United States.
Majid SarrafzadehDepartment of Computer Science, University of California, Los Angeles, Log Angeles, 90095, California, United States.
S Ananth KarumanchiDepartment of Medicine, Cedars-Sinai Medical Center, Los Angeles, 90048, California United States.ORCID https://orcid.org/0000-0002-2281-6831
Alex A T BuiMedical & Imaging Informatics Group, University of California, Los Angeles, Los Angeles, 90095, California, United States.
Ira KurtzDepartment of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, 90095-1689, California, United States.ORCID https://orcid.org/0000-0003-2834-510X
University of California, Los Angeles · USCedars-Sinai Medical Center · US

Funding

UCLA Clinical Translational Science InstituteUL1TR001881 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARLEEN F. BROWN, ARASH NAEIM · 2016 to 2026
$118.1M
Training CoreTL1DK132768 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Elizabeta Nemeth · 2021 to 2026
$3.4M
Network CoreU2CDK129496 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ISIDRO B. SALUSKY · 2021 to 2026
$2.9M
Medical Imaging Informatics Training GrantT32EB016640 · NIBIB · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ALEX BUI, William Hsu · 2013 to 2026
$2.3M
NCATS NIH HHS UL1 TR001881NIBIB NIH HHS T32 EB016640NIDDK NIH HHS TL1 DK132768NIDDK NIH HHS U2C DK129496
6 · The paper itself

Abstract

Continuous renal replacement therapy (CRRT) is a form of dialysis prescribed to severely ill patients who cannot tolerate regular hemodialysis. However, as the patients are typically very ill to begin with, there is always uncertainty as to whether they will survive during or after CRRT treatment. Because of outcome uncertainty, a large percentage of patients treated with CRRT do not survive, utilizing scarce resources and raising false hope in patients and their families. To address these issues, we present a machine-learning-based algorithm to predict if patients will survive after being treated with CRRT. We use information extracted from electronic health records from patients who were placed on CRRT at multiple institutions to train a model that predicts CRRT survival outcome; on a held-out test set, the model achieved an area under the receiver operating curve of 0.929 (CI=0.917-0.942). Feature importance, error, and subgroup analyses identified consistently, mean corpuscular volume as a driving feature for model predictions. Overall, we demonstrate the potential for predictive machine-learning models to assist clinicians in alleviating the uncertainty of CRRT patient survival outcomes, with opportunities for future improvement through further data collection and advanced modeling.

Identifiers

PMID38014280
PMCPMC10680921
OpenAlexW4388654154

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.